NM_003981.4:c.1802C>T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_003981.4(PRC1):c.1802C>T(p.Ser601Leu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003981.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRC1 | NM_003981.4 | c.1802C>T | p.Ser601Leu | missense_variant | Exon 15 of 15 | ENST00000394249.8 | NP_003972.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRC1 | ENST00000394249.8 | c.1802C>T | p.Ser601Leu | missense_variant | Exon 15 of 15 | 1 | NM_003981.4 | ENSP00000377793.3 | ||
ENSG00000284946 | ENST00000643536.1 | n.*3564C>T | non_coding_transcript_exon_variant | Exon 35 of 35 | ENSP00000494429.1 | |||||
ENSG00000284946 | ENST00000643536.1 | n.*3564C>T | 3_prime_UTR_variant | Exon 35 of 35 | ENSP00000494429.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1802C>T (p.S601L) alteration is located in exon 15 (coding exon 15) of the PRC1 gene. This alteration results from a C to T substitution at nucleotide position 1802, causing the serine (S) at amino acid position 601 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.